{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:20:07Z","timestamp":1761571207904,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.autneu.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T12:22:51Z","timestamp":1439036571000},"page":"69-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats"],"prefix":"10.1016","volume":"193","author":[{"given":"Daisuke","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Shinzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonggang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuyoshi","family":"Nishina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autneu.2015.08.005_bb0005","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI115260","article-title":"Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans","volume":"87","author":"Anderson","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.autneu.2015.08.005_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1109\/TBME.2002.807323","article-title":"Analysis of raw microneurographic recordings based on wavelet de-noising technique and classification algorithm: wavelet analysis in microneurography","volume":"50","author":"Diedrich","year":"2003","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"10.1016\/j.autneu.2015.08.005_bb0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/cs0980627","article-title":"The increase in sympathetic nerve activity after glucose ingestion is reduced in type 1 diabetes","volume":"98","author":"Fagius","year":"2000","journal-title":"Clin. Sci."},{"key":"10.1016\/j.autneu.2015.08.005_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1529-8027.2009.00223.x","article-title":"Phrenic nerve diabetic neuropathy in rats: unmyelinated fibers morphometry","volume":"14","author":"Fazan","year":"2009","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.autneu.2015.08.005_bb0025","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1046\/j.1471-4159.1994.63051782.x","article-title":"Isoform specific reductions in Na+, K+-ATPase catalytic (\u03b1) subunits in the nerve of rats with streptozotocin-induced diabetes","volume":"63","author":"Fink","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.autneu.2015.08.005_bb0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2337\/diab.42.3.375","article-title":"Muscle sympathetic nerve activity is reduced in IDDM before overt autonomic neuropathy","volume":"42","author":"Hoffman","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.autneu.2015.08.005_bb0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1056-8727(98)00010-5","article-title":"Microneurographically determined muscle sympathetic nerve activity levels are reproducible in insulin-dependent diabetes mellitus","volume":"12","author":"Hoffman","year":"1998","journal-title":"J. Diabet. Complications"},{"key":"10.1016\/j.autneu.2015.08.005_bb0040","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2337\/dc05-2370","article-title":"Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial","volume":"29","author":"Hotta","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2015.08.005_bb0045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1464-5491.2008.02490.x","article-title":"Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat","volume":"25","author":"Hotta","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.autneu.2015.08.005_bb0050","doi-asserted-by":"crossref","first-page":"e87096","DOI":"10.1371\/journal.pone.0087096","article-title":"Efficacy and safety of aldose reductase inhibitor for the treatment of diabetic cardiovascular autonomic neuropathy: systematic review and meta-analysis","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autneu.2015.08.005_bb0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0168-8227(99)00015-7","article-title":"Long-term effect of epalrestat on cardiac autonomic neuropathy in subjects with non-insulin dependent diabetes mellitus","volume":"43","author":"Ikeda","year":"1999","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.autneu.2015.08.005_bb0060","doi-asserted-by":"crossref","first-page":"H215","DOI":"10.1152\/ajpheart.00661.2012","article-title":"Streptozotocin-induced diabetes differentially affects sympathetic innervation and control of plantar metatarsal and mesenteric arteries in the rat","volume":"304","author":"Johansen","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.autneu.2015.08.005_bb0065","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00259-005-1865-1","article-title":"Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG","volume":"32","author":"Kiyono","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.autneu.2015.08.005_bb0070","first-page":"1677","article-title":"Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozotocin-induced diabetic rats","volume":"38","author":"Kurata","year":"1997","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.autneu.2015.08.005_bb0075","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00125-004-1663-5","article-title":"Sural nerve pathology in diabetic patients with minimal but progressive neuropathy","volume":"48","author":"Malik","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.autneu.2015.08.005_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0165-0270(03)00234-6","article-title":"Microneurography in anesthetized rats for the measurement of sympathetic nerve activity in the sciatic nerve","volume":"131","author":"Nakamura","year":"2003","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.autneu.2015.08.005_bb0085","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2337\/diacare.24.6.1093","article-title":"Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy","volume":"24","author":"Nakayama","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.autneu.2015.08.005_bb0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/exnr.1998.6821","article-title":"Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis\/secretion of nerve growth factor","volume":"151","author":"Ohi","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.autneu.2015.08.005_bb0095","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.jnen.0000228199.89420.90","article-title":"Identification of changes in gene expression in dorsal root ganglia in diabetic neuropathy: correlation with functional deficits","volume":"65","author":"Price","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.autneu.2015.08.005_bb0100","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10047-013-0700-x","article-title":"Effects of electrical microstimulation of peripheral sympathetic nervous fascicle on glucose uptake in rats","volume":"16","author":"Sato","year":"2013","journal-title":"J. Artif. Organs"},{"key":"10.1016\/j.autneu.2015.08.005_bb0105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jdiacomp.2009.07.005","article-title":"Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review","volume":"24","author":"Schemmel","year":"2010","journal-title":"J. Diabet. Complications"},{"key":"10.1016\/j.autneu.2015.08.005_bb0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2337\/diab.38.5.569","article-title":"Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats","volume":"38","author":"Schmidt","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.autneu.2015.08.005_bb0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2337\/diab.40.5.574","article-title":"Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats","volume":"40","author":"Schmidt","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.autneu.2015.08.005_bb0120","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/00005072-199812000-00010","article-title":"Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy","volume":"57","author":"Schmidt","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.autneu.2015.08.005_bb0125","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/jnen\/60.12.1153","article-title":"Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes","volume":"60","author":"Schmidt","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.autneu.2015.08.005_bb0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.expneurol.2004.12.018","article-title":"A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes","volume":"192","author":"Schmidt","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.autneu.2015.08.005_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.autneu.2013.06.005","article-title":"Characteristics of spike rate of peripheral sympathetic nervous signal in streptozotocin-induced diabetic rats","volume":"179","author":"Shinzawa","year":"2013","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.autneu.2015.08.005_bb0140","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/WNL.57.9.1701","article-title":"Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy","volume":"57","author":"Smith","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2015.08.005_bb0145","first-page":"E298","article-title":"Ventromedial hypothalamic stimulation enhances peripheral glucose uptake in anesthetized rats","volume":"261","author":"Sudo","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.autneu.2015.08.005_bb0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.60.1.108","article-title":"The spectrum of neuropathy in diabetes and impaired glucose tolerance","volume":"60","author":"Sumner","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.autneu.2015.08.005_bb0155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2013.07.017","article-title":"Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms","volume":"719","author":"Sytze Van Dam","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.autneu.2015.08.005_bb0160","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(25)21830-4","article-title":"Effects of a new aldose reductase inhibitor on various tissues in vitro","volume":"229","author":"Terashima","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.autneu.2015.08.005_bb0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.2040-1124.2010.00070.x","article-title":"Mechanism of diabetic neuropathy: where are we now and where to go?","volume":"24","author":"Yagihashi","year":"2011","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.autneu.2015.08.005_bb0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2337\/diab.36.1.6","article-title":"Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats","volume":"36","author":"Yoshida","year":"1987","journal-title":"Diabetes"}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070215300199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070215300199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:07:18Z","timestamp":1761566838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070215300199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":34,"alternative-id":["S1566070215300199"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2015.08.005","relation":{},"ISSN":["1566-0702"],"issn-type":[{"type":"print","value":"1566-0702"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}